Syncom Formulations Share Price Target 2024-2030 Fundamentals & Quarterly Results

by

Syncom Formulations Share Price Target 2024 2025 2026 2027 2028 2029 2030 Fundamentals & Quarterly Results – Syncom Formulation (India) Ltd involved in pharmaceuticals industry. They have three segments consisting of manufacturing and dealing with pharmaceutical drugs and formulations, trading in commodities, and renting out properties. The Company produces various pharmaceutical formulation products such as tablets, capsules, liquids orals, vials containing liquid solutions, ampoule injections (liquid), dry powder vials for injections (vial), dry syrup formulations, ointments, inhalers and herbals. Its Products include generic medicines; antivirals; antidepressants; cough suppressants; electrolytes; histamine agents (anti-allergy medicines); estrogen substances plus many others. The highest revenue generation mainly comes from the pharmaceutical drugs and formulations segment.SYNCOM FORMULATIONS Share Price Target

Latest Update – Since last year same period, Syncom Formulations (India) Ltd has seen a rise of up to 73.41% in its net profit. The company reported ₹7.63Cr for the first quarter of 2024-2025. Moreover, Syncom Formulations (India) Ltd has experienced a growth of 3.11% in its net income during the last three months.

Syncom Formulations Overview

Since its inception in 1995, Syncom Formulations is a global pharmaceutical company that specializes in the manufacturing and marketing of a wide range of health-related products. More than 400 products have been registered under this company’s name as it operates broadly as generic player across over 15 countries worldwide.

Company Name Syncom Formulations ltd
ListedNSE & BSE
Head Office7, Niraj Industrial Estate, Off Mahakali Caves Road, Andheri (East), Mumbai – 400 093,
Board Of Director
  • Mr.Ankit Jain Addnl.Independent Director
  • Mr.Ritesh Kumar Lunkad Addnl.Independent Director
  • Mr.Kedarmal Shankarlal Bankda Exe.Chairman & W T D
  • Mr.Praveen Jindal Independent Director
  • Mr.Vinod Kumar Kabra Independent Director
  • Mr.Krishna Das Neema Independent Director
  • Mrs.Ruchi Jindal Independent Woman Director
  • Mr.Vijay Shankarlal Bankda Managing Director
  • Mrs.Rinki Ankit Bankda Whole Time Director
Official Websitesyncomformulations.com

Also Check Tata Chemicals Share Price Target

Syncom Formulations Business Profile

The firm produces as well as sells more than 500 pharmaceuticals products that come in different dosage forms such as Tablets, Capsules, Liquids Orally, Liquid Vials and Ampoule Injections & Dry Vial injection systems, Dry Syrups, Ointments and Nebulizers. Additionally, it is engaged in managing properties and dealing with trade goods.

Also Check Jain Irrigation Share Price Target

The division of the company that deals with domestic products has different divisions which are: Cratus Life Care, Cratus Evolve as well as Cratus Right Nutrition. The products offered by the company include Ciprofloxacin Tablets- USP 250 mg, Ciprofloxacin Tablets- USP 500 mg, Ciprofloxacin Tablets- USP 750 mg, Cefazolin For Injection- USP 1 gm, Cefotaxime For Injection- USP 1 gm, Ceftriaxone for Injection- USP 500 mg, Cefuroxime For Injection-USP 750 mg and Gentamicin Injection- BP 40 mg.

Also Check Indian Overseas Bank Share Price Target

Business Divisions

International – Around 25 countries are operated by Syncom which has more than 400 products that are registered under it, and all this is taken care of by the international division.

Domestic- The local division is managed through CRATUS which operates in three sub-sectors; Lifecare, Evolve (Women’s Health) as well as Nutrition (Vitamins and Supplements).

Also Check Jyoti CNC Share Price Target

Expansion Projects

At the start of December 2020, the company initiated its expansion programme by increasing the overall capacity for injectable production from 2 crores to 3 crores per annum and to modernize the tablet department with an outlay of Rs 40 crores. For injectables, the expanded capacity commenced on 21st August 2023.

Also Check Cochin Shipyard Share Price Target

Segment Performance

Pharmaceutical Drug & Formulations – 88%
Trading of Commodity – 11%
Renting of Property – 1%

Revenue Breakup
Tablets – 48%
Injectables – 17%
Capsules – 4%
Liquids – 3%
Ointment – 2%
Dry Powder – 1%
Others – 25%

Also Check Apollo Tyres Share Price Target

Syncom Formulations Fundamentals & Quarterly Results

ParameterValue
Market Cap₹ 2,188 Cr.
Current Price₹ 23.3
High / Low₹ 24.2 / 7.25
Stock P/E81.0
Book Value₹ 3.05
Dividend Yield0.00 %
ROCE (Return on Capital Employed)10.4 %
ROE (Return on Equity)8.72 %
Face Value₹ 1.00
FCF (Free Cash Flow) Previous Annual₹ -10.1 Cr.
Debt to Equity Ratio0.25
Debt (preceding year)₹ 83.2 Cr.
Reserves₹ 192 Cr.
Quick Ratio2.54
Current Ratio2.76
Free Cash Flow₹ -14.1 Cr.

Also Check NBCC Share Price Target

Syncom Formulations Quarterly Results

PeriodJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales51.4054.4957.3861.3759.3662.3963.3473.2786.83
Expenses47.9250.2051.4755.4353.2156.2956.5564.4676.35
Operating Profit3.484.295.915.946.156.106.798.8110.48
OPM %6.77%7.87%10.30%9.68%10.36%9.78%10.72%12.02%12.07%
Other Income2.982.871.986.791.884.004.332.871.31
Interest0.500.620.721.291.121.081.081.170.39
Depreciation1.001.181.201.171.100.881.451.301.30
Profit Before Tax4.965.365.9710.275.818.148.599.2110.10
Tax %22.18%33.02%30.49%17.62%26.85%23.71%25.38%26.71%24.46%
Net Profit3.873.604.158.474.256.216.426.757.63
EPS (₹)0.040.040.040.090.050.070.070.070.08

Also Check ZEEL Share Price Target

CAGR Report

Metric10 Years5 Years3 YearsTTM/1 Year
Compounded Sales Growth6%7%2%23%
Compounded Profit Growth10%16%-7%32%
Stock Price CAGR15%95%55%152%
Return on Equity (ROE)10%11%9%9%

Syncom Formulations Shareholding Pattern

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Jun 2024
Promoters38.98%38.98%40.14%41.18%46.12%50.57%50.57%50.57%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.08%0.09%
DIIs0.00%0.00%0.01%0.00%0.00%0.00%0.00%0.00%
Public61.02%61.02%59.85%58.82%53.88%49.44%49.35%49.34%
No. of Shareholders39,23341,12639,18072,7362,32,6172,27,4783,25,7613,76,530

Also Check L&T Finance Share Price Target

Syncom Formulations Share Price Target 2024-2030 Forecast

YearInitial TargetMid-Year TargetYear-End Target
2024₹17.9₹24.34₹28.21
2025₹29₹28₹34
2026₹35₹34₹40
2027₹41₹40₹49
2028₹50₹46₹55
2029₹56₹52₹61
2030₹62₹58₹67

Also Check Ambuja Cement Share Price Target

SYNCOM FORMULATIONS Share Price Target 2025

MonthTarget
January₹29
February₹30
March₹31
April₹30
May₹29
June₹28
July₹29
August₹30
September₹31
October₹32
November₹33
December₹34

SYNCOM FORMULATIONS Share Price Target 2026

MonthTarget
January₹35
February₹36
March₹37
April₹36
May₹35
June₹34
July₹35
August₹36
September₹37
October₹38
November₹39
December₹40

SYNCOM FORMULATIONS Share Price Target 2027

MonthTarget
January₹41
February₹42
March₹43
April₹42
May₹41
June₹40
July₹42
August₹44
September₹46
October₹47
November₹48
December₹49

SYNCOM FORMULATIONS Share Price Target 2028

MonthTarget
January₹50
February₹51
March₹52
April₹50
May₹48
June₹46
July₹48
August₹50
September₹52
October₹53
November₹54
December₹55

SYNCOM FORMULATIONS Share Price Target 2029

MonthTarget
January₹56
February₹57
March₹58
April₹56
May₹54
June₹52
July₹54
August₹56
September₹58
October₹59
November₹60
December₹61

SYNCOM FORMULATIONS Share Price Target 2030

MonthTarget
January₹62
February₹63
March₹64
April₹62
May₹60
June₹58
July₹60
August₹62
September₹64
October₹65
November₹66
December₹67

Official Website – syncomformulations.com

Leave a Comment